WorldPingSTAT
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
WorldPingMimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT